Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment...
21 insider purchases on record · latest filing 2026-07-16.
Insiders have also filed 3 sale transactions at ADIL.